Sunday, December 21, 2025 | 02:24 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Vaccine leadership, not chauvinism

The WHO's initiative to provide equitable access to vaccines - COVAX - is devoid of the funds needed to procure and supply the shots to poorer countries.

Coronavirus, vaccine, covid, drugs, clinical trials
premium

Covaxin is based on highly purified and inactivated two-dose Sars-Cov-2 vaccine manufactured in a vero cell manufacturing platform

Sunita Narain
Exactly one year later, the world is moving towards the next decisive phase in the fight against Covid-19. Vaccines are now available and people are being inoculated — many rich countries have set targets for full immunisation by mid-year. With this done, they say, it can be back to business.

But for this to happen, we need a hard introspection by our scientific and political leadership during this critical phase of recovery. Today, on the one hand, the virus is mutating and becoming more unpredictable and there is still too much that we do not know. For instance, it is not
Disclaimer: These are personal views of the writer. They do not necessarily reflect the opinion of www.business-standard.com or the Business Standard newspaper